Polyamino acid composite material with nerve repair promoting function and preparation method and application thereof
Polyamic acid composites prepared by electrospinning technology of polylactic acid-glycolic acid copolymer and poly(ethylene glycol) block poly(γ-benzyl-L-methionine)amines solve the existing nerve catheters Inadequacy in nerve regeneration and extension provides effective physical support and growth orientation, improving neural repair efficiency and reducing immune response.
Patent Information
- Application Number
- CN202310481498.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2043-04-27
AI Technical Summary
Existing neurocatheter products lack effective guiding functions in promoting nerve regeneration and extension, and autologous nerve transplantation has problems with limited number and poor biocompatibility, which limits its widespread use.
Preparation of polylactic acid-hydroxyglycolic acid copolymer (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine)amine (PEG-MELG) through electrospinning technology with promoting nerve repair Functional polyamino acid composite materials form biomedical nerve repair cannulas, providing physical support and growth orientation.
This material promotes the repair and growth of neuronal axons by finely regulating interface structure and biomechanical characteristics, provides a closed environment, reduces external interference, improves neural repair efficiency, and reduces immune response.
Smart Images

Figure CN116421782B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a polyamino acid composite material with a function of promoting nerve repair, a preparation method and application thereof, and belongs to the technical field of medical biomaterials. Background Art
[0002] Nerve injury is common in partial or complete damage to nerve cells caused by various traumas and other conditions. It is one of the common and frequent types of clinical injuries, which often leads to sensory and motor dysfunction or loss in patients, seriously affecting the daily quality of life and work efficiency of patients. It is urgent to find effective treatment measures for nerve injury; neural tissue regeneration engineering has become a research boom in the treatment of repairing nervous system injuries. The key is to use materials to support the growth of nerve cells. Better materials can serve as the attachment matrix of implanted cells or host neural stem cells, and they themselves or their degradation products can also promote the growth of nerve cells; for example, the use of nerve guide conduits (NGCs) can provide a variety of favorable conditions for regeneration after nerve rupture or long-distance truncation. In nerve regeneration, it can temporarily fix and support the two ends of the defective nerve, guide the axial growth of the axons of the neurons, avoid exogenous growth and the formation of neuromas, provide a relatively isolated microenvironment for nerve regeneration, enrich the neurotrophic factors required for nerve regeneration, reduce the invasion of exogenous cells, and prevent the formation of glial scars.
[0003] Peripheral nerve injury is generally caused by trauma, ischemia, etc. Excessive fiber deposition and scar formation at the distal injured nerve affect nerve signal transmission, functional loss and even neuropraxia. Due to its complex structure and function, peripheral nerve tissue has a high disability rate, poor prognosis and difficulty in treatment once it is injured, which has become a major clinical problem. Peripheral nerve injury may cause sensory and motor dysfunction and irreversible tissue atrophy, resulting in a decrease in the patient's quality of life and a heavy burden on society. Therefore, due to the specificity of the structure and function of peripheral nerves and the pathological process, peripheral nerve injury has always been the most challenging problem in trauma surgery.
[0004] At present, in clinical practice, for shorter-distance nerve rupture injuries (<5mm), the two ends of the broken nerve are generally directly anastomosed; for more serious long-distance nerve defects (>10mm), the tension is too high when sutured directly, and autologous nerve transplantation or implantation of other nerve repair materials is required to reduce the suture tension and assist nerve growth. However, autologous nerve transplantation has problems such as limited quantity, poor biocompatibility, and difficult to control tissue similarity. It can also cause problems such as sensory and functional disorders in the innervated area of the donor nerve, which greatly limits its widespread application. Therefore, there is an urgent need to find new nerve repair materials in clinical practice.
[0005] At present, the nerve catheter products that have been marketed at home and abroad, for example: 1. Patent application CN202210377724.2 discloses a double-layer tubular product for promoting the regeneration of defective nerves, which is composed of a tubular outer layer and a tubular inner layer close to its inner wall, the tubular outer layer is formed by a human body compatible biodegradable material, and the tubular inner layer is a hydrogel layer formed by polyethylene glycol. The human body compatible biodegradable material is selected from: polylactic acid or its derivatives, gelatin and its derivatives, chitosan, polyurethane, polycaprolactone, water-insoluble cellulose and its derivatives, etc. The polylactic acid derivative is selected from: polylactic acid-polyethylene glycol copolymer, lactic acid-glycolic acid copolymer (PLGA), PLGA-polyethylene glycol copolymer, lactic acid-caprolactone copolymer (PCLA), PCLA-polyethylene glycol copolymer. The weight ratio of the tubular outer layer to the tubular inner layer is 100:20-100, and the thickness of the tube wall of the double-layer tubular product is 50-500μm. 2. Patent application CN202110504965.4 discloses a method for preparing a nerve conduit that releases hydrogen sulfide in response to active oxygen, wherein the conduit includes a fiber conduit, the interior of which is filled with a thermosensitive polyamino acid hydrogel, and the interior of the thermosensitive polyamino acid hydrogel is loaded with polyamino acid nano-micelles, and the polyamino acid nano-micelles are loaded with an active oxygen-responsive hydrogen sulfide donor, and the active oxygen-responsive hydrogen sulfide donor includes aryl borate functionalized peroxythiocarbamate and its derivatives. This method uses the active oxygen environment excessively produced by peripheral nerve damage to activate the hydrogen sulfide donor loaded in the nerve conduit, and realizes the release of hydrogen sulfide response while removing active oxygen, and then inhibits the expression of active oxygen and inflammatory factors based on the anti-inflammatory, antioxidant and macrophage polarization effects of hydrogen sulfide, and further feedback regulation avoids excessive production of hydrogen sulfide, achieving the purpose of on-demand administration, and creating a good regenerative microenvironment for damaged nerves. 3. Patent application CN200910177405.1 discloses a repair material for promoting regeneration of defective nerves, which includes a biodegradable material compatible with the human body and a polymer material pore-forming agent, and the use of the pore-forming agent in preparing a repair material for promoting regeneration of defective nerves.
[0006] However, the main functions of existing nerve catheter products are still to provide basic physical support for damaged nerve regeneration, connect stumps, and protect against compression from surrounding tissues. Most products have not effectively integrated new biomedical materials for in-depth and targeted optimization. The current commercially available nerve catheter products still lack the ability to guide nerve regeneration and extension.
[0007] The development of biomedical materials has gone through three major stages. The first generation of biomaterials is mainly composed of various bio-inert materials, including bone nails, bone plates and artificial joints. The second generation of biomaterials is represented by bioactive materials such as bioactive glass, bioceramics and absorbable sutures. The third generation of biomaterials is represented by bionic materials such as tissue engineering scaffold materials and in situ tissue regeneration materials. This generation focuses more on fine-tuning the optimization of physical properties such as micro-nano structure and biomechanics of materials, or combining multiple chemical or biological factors to stimulate tissue repair.
[0008] Electrospinning technology is a technology that uses polymer solutions to spin fibers under high-voltage static electricity. Specifically, the polymer solution or melt is charged with high-voltage static electricity of several thousand to tens of thousands of volts. The charged polymer droplets are accelerated at the top of the Taylor cone of the capillary under the action of the electric field force. When the electric field force is large enough, the polymer droplets overcome the surface tension to form a jet stream. During the jetting process of the stream, the solvent evaporates or solidifies, and finally falls on the receiving device to form a fiber mat similar to a non-woven fabric. Electrospinning can produce fibers with a diameter of tens to hundreds of nanometers. The products have a high porosity and a large specific surface area, diversified components, and uniform diameter distribution. They have high application value in the fields of biomedicine, environmental engineering, and textiles. Summary of the invention
[0009] In view of the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a composite material of polyamino acid having the function of promoting nerve repair.
[0010] According to the first embodiment of the present invention, a polyamino acid composite material having a function of promoting nerve repair is provided, which is made of polylactic acid-co-glycolic acid (PLGA) and poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-co-glycolic acid and the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine is 20-24:76-80, preferably 21-23:77-79, preferably 23:77.
[0011] The poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is a polyethylene glycol-modified polymethionine material, which is one of many polyethylene glycol-polyamino acid block copolymers. Polyethylene glycol is a high molecular organic substance that is widely used in the chemical and pharmaceutical fields and has many excellent properties such as water solubility, non-volatility, and physiological inertness. The present application utilizes the amphiphilic copolymer of polyethylene glycol to be adsorbed on the surface of the material to further improve the biocompatibility of the nerve cuff and facilitate the purification of the product.
[0012] According to a second embodiment of the present invention, there is provided a method for preparing a polyamino acid composite material having a function of promoting nerve repair, comprising the following steps:
[0013] (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine)amine in an organic solvent, stirring and mixing to obtain an electrospinning stock solution;
[0014] (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump, and the product is received by a cylindrical metal rotating receiving disk to obtain a blended spun yarn;
[0015] (3) After the electrospinning process is completed and all the blended filaments are received by the cylindrical metal rotating receiving disk, the receiving speed of the receiving disk is adjusted to obtain a blended fiber membrane;
[0016] (4) The obtained blended fiber membrane is sent to a vacuum drying oven for vacuum drying to remove the residual solvent, thereby obtaining the polyamino acid composite material having the function of promoting nerve repair.
[0017] Furthermore, as a more preferred embodiment of the present invention, in step (1), the stirring is at room temperature for 12 h to 16 h; the organic solvent is selected from hexafluoroisopropanol or dichloromethane; preferably 13 h to 15 h; preferably 12 h to 15 h; preferably 14 h to 15 h.
[0018] Furthermore, as a more preferred embodiment of the present invention, in step (1), in the electrospinning stock solution: the mass percentage of the polylactic acid-co-glycolic acid (PLGA) is 8.6-12.3%; preferably 8.8-12.0%; preferably 9-12%; preferably 9.5-11.5%; preferably 10-11%.
[0019] Furthermore, as a more preferred embodiment of the present invention, in step (1), the mass percentage of the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) is 18.2-23.1%; preferably 18.5-23.0%; preferably 19-22%; preferably 20-21%.
[0020] Further, as a more preferred embodiment of the present invention, in step (2), the injection speed of fibrinogen during the electrospinning process is 1-3 ml / h, the loading voltage is 10-20 kV, and the receiving distance is 5-25 cm; preferably, the speed is 1.5-2.5 ml / h, the loading voltage is 12-18 kV, and the receiving distance is 10-20 cm; preferably, the speed is 1-2 ml / h, the loading voltage is 10-15 kV, and the receiving distance is 5-15 cm; preferably, the speed is 2-3 ml / h, the loading voltage is 15-20 kV, and the receiving distance is 15-25 cm.
[0021] Furthermore, as a more preferred embodiment of the present invention, in step (2), the diameter of the blended spun yarn is 1.5 to 2.5 μm; preferably 1.6 to 2.2 μm; preferably 2.0 to 2.5 μm; preferably 1.5 to 2.0 μm.
[0022] Furthermore, as a more preferred embodiment of the present invention, in step (2), the receiving speed of the cylindrical metal rotating receiving disk is adjusted to 700-2000 r / h; preferably 800-1800 r / h; preferably 1000-1500 r / h; preferably 1500-2000 r / h.
[0023] Further, as a more preferred embodiment of the present invention, in step (4), the vacuum degree of the vacuum drying is 0.03Mpa~0.06Mpa, the temperature is 18℃~23℃, and the time is 36~48h; preferably, the vacuum degree is 0.04Mpa~0.05Mpa, the temperature is 19℃~22℃, and the time is 40~45h; preferably, the vacuum degree is 0.04Mpa~0.06Mpa, the temperature is 20℃~23℃, and the time is 38~48h; preferably, the vacuum degree is 0.03Mpa~0.05Mpa, the temperature is 18℃~20℃, and the time is 39~45h.
[0024] According to a third embodiment of the present invention, there is provided an application of a polyamino acid composite material having a function of promoting nerve repair obtained by the preparation method described above in the field of biomedical materials for preparing a biomedical nerve repair sleeve.
[0025] Furthermore, as a more preferred embodiment of the present invention, the wall thickness of the biomedical nerve repair sleeve is 0.1-0.3 mm; preferably 0.15-0.25 mm; preferably 0.2-0.3 mm; preferably 0.1-0.2 mm.
[0026] The sleeve is a bioabsorbable, white sleeve tube that can effectively serve as a barrier in a closed environment and provide sufficient closed growth space for damaged nerves. At the same time, it can simulate the in vivo growth environment to the greatest extent, provide good space and mechanical properties for nerve repair, and accelerate the efficiency of nerve repair.
[0027] According to a fourth embodiment of the present invention, there is provided a cannula having a function of promoting nerve repair, wherein the cannula is made by using a polyamino acid composite material made by the preparation method described above and curling the polyamino acid composite material into an inner diameter of 2 mm to 5 mm and a length of 3 cm to 5 cm through a tube rolling and cutting technology, and the cannula is suitable for clinical treatment of peripheral nerve injuries not exceeding 20 mm.
[0028] Principle of this application: In recent years, there has been increasing evidence that implantable materials, micro-nanostructures and biomechanical regulation can affect and even reshape the microenvironment of peripheral nerve injury. Because the occurrence and growth of neurons always depend on the interaction with extracellular components and intercellular communication in the dynamic microenvironment. The mechanical properties of the extracellular substrate can regulate the signal transduction of axonal biological activities, such as electrical conduction and protein transport. Soft materials close to neural tissue or with an elastic modulus of <1kPa can promote neuronal vitality and neurite extension. 【1】 Cells have a very sensitive response to their local microenvironment. The present invention uses PLGA and PEG-MELG as raw materials, adopts electrospinning technology to prepare composite materials, and uses the prepared composite materials to prepare nerve repair sleeves. While providing basic physical support, connecting stumps, and protecting against surrounding tissue compression, the local microenvironment of peripheral nerves is reconstructed by precisely regulating the interface structure and biomechanical properties, providing guidance for the directional growth of neuronal axons, and through fine material ratios, the degradation cycle is matched with the repair cycle, so as to achieve the purpose of promoting nerve repair safely and efficiently.
[0029] References: [1] Stukel, JM; Willits, RKMechanotransduction of NeuralCells Through Cell-Substrate Interactions. Tissue engineering. Part B, Reviews2016, 22, 173-182, doi:10.1089 / ten.TEB.2015.0380.
[0030] Compared with the prior art, the technical solution provided by this application has the following advantages:
[0031] 1. The present application innovatively uses poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG), adopts poly(lactic acid-glycolic acid copolymer) (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG) as raw materials, blends them into a blended fiber membrane through electrospinning technology, and then vacuum dries to obtain a polyamino acid composite material with the function of promoting nerve repair, which has better mechanical support, can promote the repair of nerve cell axons, and guide the attachment and growth of growth cones.
[0032] 2. The polyamino acid composite material of the present application can be made into a curled nerve tissue repair sleeve through tube rolling and cutting technology. The polyamino acid composite material provides a relatively closed space for nerve repair without interference from other tissues, provides guidance and protection for the repair of nerve axons, and at the same time utilizes the special structural advantages of the material to promote nerve regeneration and extension.
[0033] 3. The present application adopts electrospinning technology to prepare polyamino acid composite materials, which facilitates the later better construction of the microscopic surface structure of the polyamino acid composite materials, limits the injection speed of fibrinogen to 1-3 ml / h, the loading voltage to 10-20 kV, the receiving distance to 5-25 cm, the blended spinning diameter to 1.5-2.5 μm, and adjusts the rotation receiving speed to 700-2000 r / h, so that the polyamino acid composite materials not only have better mechanical support, but also can promote the repair of nerve cell axons and guide the climbing growth of growth cones. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is a process flow chart of the preparation of the polyamino acid composite material having the function of promoting nerve repair in the present application;
[0035] Figure 2 This is the SFI score chart of sciatic nerve function after surgery of cannula experimental mice prepared in Example 1 and Comparative Example 6 of the present application;
[0036] Figure 3 This is a CD3 lymphocyte staining (20X) image of the tissue sections of the surgical area of the cannula experimental animals prepared in Example 1 and Comparative Example 6 of the present application;
[0037] Figure 4 This is a schematic diagram of the structure of a nerve repair sleeve with the function of promoting nerve repair prepared by the method of the present application. DETAILED DESCRIPTION
[0038] In order to enable those skilled in the art to better understand the technical solutions in the present application, the technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection of this application.
[0039] It should be noted that the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of this application, the meaning of "multiple" and "several" is two or more, unless otherwise clearly and specifically defined.
[0040] It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the conditions under which this application can be implemented. Therefore, they have no substantive technical significance. Any structural modification, change in proportional relationship or adjustment of size should still fall within the scope of the technical content disclosed in this application without affecting the effects and purposes that can be achieved by this application.
[0041] In recent years, polyamino acid materials have shown great potential application value in biological applications such as antibacterial, antifouling, anti-tumor, gene delivery, tissue engineering and immunomodulation.
[0042] According to the first embodiment of the present invention, a polyamino acid composite material having a function of promoting nerve repair is provided, which is made of polylactic acid-co-glycolic acid (PLGA) and poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-co-glycolic acid and the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine is 20-24:76-80, preferably 21-23:77-79, preferably 23:77.
[0043] It should be noted that the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine used in the present application is a high molecular weight organic substance, which is widely used in the chemical and pharmaceutical fields and has many excellent properties: water solubility, non-volatility, physiological inertness, etc. The present application utilizes the amphiphilic copolymer of poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine to be adsorbed on the surface of the material to further improve the biocompatibility of the nerve cuff and facilitate the purification of the product.
[0044] According to a second embodiment of the present invention, there is provided a method for preparing a polyamino acid composite material having a function of promoting nerve repair, comprising the following steps:
[0045] (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine)amine in an organic solvent, stirring and mixing to obtain an electrospinning stock solution;
[0046] (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump, and the product is received by a cylindrical metal rotating receiving disk to obtain a blended spun yarn;
[0047] (3) After the electrospinning process is completed and all the blended filaments are received by the cylindrical metal rotating receiving disk, the receiving speed of the receiving disk is adjusted to obtain a blended fiber membrane;
[0048] (4) The obtained blended fiber membrane is sent to a vacuum drying oven for vacuum drying to remove the residual solvent, thereby obtaining the polyamino acid composite material having the function of promoting nerve repair.
[0049] It should be noted that the polyamino acid composite material prepared in the present application has the same primary structure (amino acid residues and peptide bonds) and similar secondary structure (α-helix and β-fold) as natural protein and polypeptide materials. These characteristics are its inherent advantages as a biomaterial.
[0050] Specifically, in an embodiment of the present invention, in step (1), stirring is performed at room temperature for 12 h to 16 h; and the organic solvent is selected from hexafluoroisopropanol or dichloromethane.
[0051] Specifically, in an embodiment of the present invention, in step (1), in the electrospinning stock solution: the mass percentage of the poly(lactic acid-co-glycolic acid) (PLGA) is 8.6-12.3%, and the mass percentage of the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) is 18.2-23.1%.
[0052] Specifically, in an embodiment of the present invention, in step (2), the injection rate of fibrinogen during the electrospinning process is 1 to 3 ml / h, the loading voltage is 10 to 20 kV, and the receiving distance is 5 to 25 cm.
[0053] Specifically, in the embodiment of the present invention, in step (2), the diameter of the blended spun yarn is 1.5 to 2.5 μm.
[0054] Specifically, in the embodiment of the present invention, in step (2), the receiving speed of the cylindrical metal rotating receiving disk is adjusted to 700-2000 r / h.
[0055] Specifically, in the embodiment of the present invention, in step (4), the vacuum degree of vacuum drying is 0.03Mpa-0.06Mpa, the temperature is 18°C-23°C, and the time is 36-48h.
[0056] According to a third embodiment of the present invention, there is provided an application of a polyamino acid composite material having a function of promoting nerve repair obtained by the preparation method described above, which is used for preparing a biomedical nerve repair sleeve.
[0057] Specifically, in the embodiment of the present invention, the wall thickness of the biomedical nerve repair sleeve is 0.1-0.3 mm.
[0058] Example 1
[0059] like Figure 1 , Figure 2 , Figure 3, Figure 4 As shown, a polyamino acid composite material with the function of promoting nerve repair is made of polylactic acid-glycolic acid copolymer (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-glycolic acid copolymer and the poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is 23:77.
[0060] A method for preparing a polyamino acid composite material having a function of promoting nerve repair comprises the following steps:
[0061] (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine) amine in hexafluoroisopropanol, stirring at room temperature for 13 h to mix evenly, to obtain an electrospinning stock solution; in the electrospinning stock solution, the mass percentage of the poly(lactic acid-co-glycolic acid) (PLGA) is 10%, and the mass percentage of the poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine) is 20%;
[0062] (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump. During the electrospinning process, the injection rate of fibrinogen is 1 ml / h, the loading voltage is 10 kV, the receiving distance is 5 cm, and the product is received by a cylindrical metal rotating receiving disk. The receiving speed of the receiving disk is adjusted to 700 r / h to obtain a blended filament with a diameter of 1.5 μm;
[0063] (3) After the electrospinning treatment is completed, when all the blended filaments are received by the cylindrical metal rotating receiving disk, a blended fiber membrane is obtained;
[0064] (4) The blended fiber membrane obtained above is sent to a vacuum drying oven for vacuum drying. The vacuum degree of vacuum drying is 0.03 MPa, the temperature is 18° C., and the time is 36 hours to remove the residual solvent to obtain the polyamino acid composite material with the function of promoting nerve repair.
[0065] An application of the polyamino acid composite material with the function of promoting nerve repair obtained by the preparation method as described above is used to prepare a biomedical nerve repair sleeve, wherein the wall thickness of the biomedical nerve repair sleeve is 0.1 mm.
[0066] Example 2
[0067] like Figure 1 , Figure 4As shown, a polyamino acid composite material with the function of promoting nerve repair is made of polylactic acid-glycolic acid copolymer (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-glycolic acid copolymer and the poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is 20:80.
[0068] A method for preparing a polyamino acid composite material having a function of promoting nerve repair comprises the following steps:
[0069] (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) amine in dichloromethane, stirring at room temperature for 12 hours to mix evenly, to obtain an electrospinning stock solution; in the electrospinning stock solution, the mass percentage of the poly(lactic acid-co-glycolic acid) (PLGA) is 8.6, and the mass percentage of the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) is 18.2;
[0070] (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump. During the electrospinning process, the injection rate of fibrinogen is 3 ml / h, the loading voltage is 20 kV, the receiving distance is 25 cm, and the product is received by a cylindrical metal rotating receiving disk. The receiving speed of the receiving disk is adjusted to 2000 r / h to obtain a blended filament with a diameter of 2.5 μm;
[0071] (3) After the electrospinning treatment is completed, when all the blended filaments are received by the cylindrical metal rotating receiving disk, a blended fiber membrane is obtained;
[0072] (4) The blended fiber membrane obtained above is sent to a vacuum drying oven for vacuum drying. The vacuum degree of vacuum drying is 0.04 MPa, the temperature is 20° C., and the time is 48 hours to remove the residual solvent to obtain the polyamino acid composite material with the function of promoting nerve repair.
[0073] An application of the polyamino acid composite material with the function of promoting nerve repair obtained by the preparation method as described above is used to prepare a biomedical nerve repair sleeve, and the wall thickness of the biomedical nerve repair sleeve is 0.3mm.
[0074] Example 3
[0075] like Figure 1 , Figure 4As shown, a polyamino acid composite material with the function of promoting nerve repair is made of polylactic acid-glycolic acid copolymer (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-glycolic acid copolymer and the poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is 23:77.
[0076] A method for preparing a polyamino acid composite material having a function of promoting nerve repair comprises the following steps:
[0077] (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine) amine in hexafluoroisopropanol, stirring at room temperature for 16 hours to mix evenly, and obtaining an electrospinning stock solution; in the electrospinning stock solution, the mass percentage of the poly(lactic acid-co-glycolic acid) (PLGA) is 12.3%, and the mass percentage of the poly(ethylene glycol)-block-poly(γ-benzyl-L-methionine) is 23.1%;
[0078] (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump, wherein the injection rate of fibrinogen during the electrospinning process is 2 ml / h, the loading voltage is 15 kV, the receiving distance is 15 cm, and the product is received by a cylindrical metal rotating receiving disk, and the receiving speed of the receiving disk is adjusted to 1400 r / h, to obtain a blended filament with a diameter of 2.0 μm;
[0079] (3) After the electrospinning treatment is completed, when all the blended filaments are received by the cylindrical metal rotating receiving disk, a blended fiber membrane is obtained;
[0080] (4) The blended fiber membrane obtained above is sent to a vacuum drying oven for vacuum drying. The vacuum degree of vacuum drying is 0.06 MPa, the temperature is 23° C., and the time is 42 h to remove the residual solvent to obtain the polyamino acid composite material with the function of promoting nerve repair.
[0081] An application of the polyamino acid composite material with the function of promoting nerve repair obtained by the preparation method as described above is used to prepare a biomedical nerve repair sleeve, wherein the wall thickness of the biomedical nerve repair sleeve is 0.2 mm.
[0082] Comparative Example 1
[0083] The difference from Example 1 is that the receiving speed of the cylindrical metal rotating receiving disk is adjusted to 500 r / h, and other conditions remain unchanged.
[0084] Comparative Example 2
[0085] The difference from Example 1 is that: a nerve repair composite material does not add poly(ethylene glycol)-block poly(γ-benzyl-L-methionine)amine (PEG-MELG), PEG-MELG is replaced by PGA, and other conditions remain unchanged.
[0086] The cannula prepared in Comparative Example 2 was tested by using a catheter implantation local immunohistochemical staining experimental method. The test results show that the co-spun fiber membrane prepared by the method of Comparative Example 2 cannot regulate the degradation cycle, and will cause severe inflammatory reactions and cannot promote nerve repair.
[0087] Comparative Example 3
[0088] The difference from Example 1 is that: a nerve repair composite material is made of polylactic acid-glycolic acid copolymer (PLGA) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine (PEG-MELG), wherein the mass ratio of the polylactic acid-glycolic acid copolymer and the poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is 15:85, and other conditions remain unchanged.
[0089] Referring to the relevant test steps of 4.3 of mechanical test method for bracket of standard JIS T0401-2013, the blended spun fiber membrane product prepared in comparative example 3 was placed intact on a parallel plate fixture so that the instrument could measure the radial force of the product. At (37±2)°C, the sleeve was compressed at a uniform speed of 2mm / min until the outer diameter was reduced by 50%, and the load required to cause the sleeve to deform its outer diameter by 50% was measured.
[0090] After testing, it was found that the blended spun fiber membrane prepared by the method of Comparative Example 3 had no stress response, its anti-extrusion performance decreased, and it could not maintain the space required for nerve regeneration.
[0091] Comparative Example 4
[0092] The difference from Example 3 is that the loading voltage for bolus injection of fibrinogen is 30 kV, and other conditions remain unchanged.
[0093] Comparative Example 5
[0094] The difference from Example 3 is that the loading voltage for the fibrinogen injection is 7 kV, and other conditions remain unchanged.
[0095] According to the standard GB / T16594-2008 general rules for scanning electron microscope measurement of micron-level length, a scanning electron microscope was used to photograph the fiber surfaces of the inner tube wall and outer tube wall of the blended spinning samples obtained in Comparative Example 1, Comparative Example 4 and Comparative Example 5, and no less than 10 points (except the fiber intersection) were randomly selected on the photos to measure the fiber diameter, and the average value was taken.
[0096] After testing, the diameter of the blended spun yarn obtained by the method of comparative example 1 was 5 μm, and the designed microscopic pore structure was lost. The diameter of the blended spun yarn obtained by the method of comparative example 4 was 0.9-1.2 μm, the fiber was too thin, and the mechanical support effect was poor. The diameter of the blended spun yarn obtained by the method of comparative example 5 was 3.3-4.0 μm, the fiber was too thick, and the designed microscopic pore structure was lost, which could not promote the repair of nerve cell axons, nor guide the growth of growth cones.
[0097] Comparative Example 6
[0098] Commercial products Nerve Guide, registration number: NGC2020082111, manufacturer: Polyganics Innovations BV (Rozenburglaan), Netherlands.
[0099] 1. Evaluation of nerve repair effects
[0100] 1. Sciatic nerve function index (SFI) test
[0101] Detection method and standard: The sciatic nerve function index (SFI) was used for detection. The specific method was as follows: a wooden trough with a length of 60 cm, a width of 10 cm, and a height of 10 cm was made, and 70 g of white paper was cut into the same length and width as the wooden trough and then laid on the bottom of the trough. After the rat's hind limbs were dyed with pigments in the ankle joints, the rat was placed at one end of the trough and allowed to walk to the other side of the trough by itself, leaving 5 to 6 footprints on each side of the hind limb. The footprints with clear imprints were selected to measure the three indicators of the normal foot (N) and the injured foot (E): A, PL (footprint length); B, TS (toe width); C, IT (intermediate toe width). The above indexes were substituted into the Bain formula to calculate the sciatic nerve function index. The Bain formula is: SFI = 109.5 (ETS-NTS) / NTS-38.3 (EPL-NPL) / NPL+13.3 (EIT-NIT) / NIT-8.8. The sciatic nerve function index SFI = 0 represents normal mice, and the sciatic nerve function index SFI = -100 represents completely injured mice.
[0102] The composite materials prepared by the methods of Example 1 and Comparative Example 6 were respectively used to prepare sleeves, and the sleeves of each group were used to perform sciatic nerve repair tests. The treatment conditions of each group are as follows:
[0103] Sham operation group: only the epidermis was cut open without sciatic nerve amputation.
[0104] Negative control group: mice underwent sciatic nerve transection surgery, but no repair surgery was performed and the nerves were sutured directly;
[0105] Example 1 group (referred to as "Example" in the accompanying drawings): After sciatic nerve axe surgery was performed on mice, repair surgery was performed using the cannula made of the polyamino acid composite material of Example 1;
[0106] Comparative Example 6 (referred to as "Comparative Example" in the accompanying drawings): After sciatic nerve axotomy was performed on mice, repair surgery was performed using the cannula made of the nerve repair composite material of Comparative Example 6.
[0107] The experimental results are as follows Figure 2 shown.
[0108] like Figure 2 As shown in the figure, compared with normal control mice, the SFI scores of all experimental mice in all groups were significantly lower 15 days after surgery. When the sham operation group was re-evaluated 30 days after surgery, it had recovered to a level close to that of normal mice, indicating that there was no nerve damage in the sham operation group. The score was lower than normal 15 days after surgery, which may be due to factors such as local edema in the surgical area and wound pain. The scores of experimental mice in the other groups that underwent sciatic nerve transection continued to decrease from 30 to 45 days after surgery, regardless of whether they underwent cannula repair or not, indicating that there was persistent nerve function damage. Among them, the negative control group without cannula repair had the most significant decrease. After 45 days, the score of the negative control group continued to decrease, while the scores of the catheter groups did not continue to decrease and began to rise slightly, indicating that with the proximal regeneration and extension of the severed nerve, nerve function and lower limb muscle strength were restored. The scores of each catheter group were significantly different from those of the negative control group (P<0.05), but there was no statistical difference between the catheter groups. 90 days after surgery, the neurological function scores of each group began to stabilize. Compared with the control score of the catheter made of the polyamino acid composite material in Example 1 of the present application and the control score of the comparative example 6 group, the example group had a higher positive score and a better nerve repair effect.
[0109] 2. Local Immunohistochemical Staining Experiment after Catheter Implantation
[0110] The composite materials prepared by the methods of Example 1 and Comparative Example 6 were respectively used to prepare cannulas, and the prepared cannulas were used to perform a catheter implantation local immunohistochemical staining experiment on experimental mice. The treatment conditions of each group are as follows:
[0111] Normal group: experimental mice were not subjected to nerve axotomy surgery and no materials were implanted;
[0112] Negative control group: experimental mice underwent nerve axotomy surgery without implantation of materials;
[0113] Example 1 group (referred to as "Example" in the accompanying drawings): experimental mice underwent nerve axe surgery and were implanted with the cannula prepared in Example 1 of the present application for repair surgery;
[0114] Comparative Example 6 (referred to as "Comparative Example" in the accompanying drawings): experimental mice underwent nerve axection surgery and were implanted with the cannula prepared in Comparative Example 6 for repair surgery.
[0115] Detection method and standard: One month after the modeling surgery, the normal group, negative control group, Example 1 group, and Comparative Example 6 group were dissected and samples were obtained. CD3 lymphocyte staining of the surgical site samples was performed to determine the local stimulation of the implanted materials in each group. The experimental results are as follows: Figure 3 shown.
[0116] Depend on Figure 3 It can be seen that after implantation of each group of nerve conduit materials, the Example 1 group and the autologous transplantation group did not show a significant increase in lymphocyte staining compared with the sham operation group and the negative control. The comparative example 6 group was a conventional chitosan nerve repair conduit experiment, and the positive lymphocyte staining of the experimental mice in the comparative example 6 group without the addition of the polyamino acid composite material of the present application increased significantly. From the experimental results, it can be seen that the cannula made of the polyamino acid composite material of the present application can reduce the potential stimulation of local immune cells.
[0117] The above description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but will conform to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for preparing a polyamino acid composite material having a function of promoting nerve repair, characterized in that: The following steps are involved: (1) dissolving poly(lactic acid-co-glycolic acid) and poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine in an organic solvent, stirring and mixing to obtain an electrospinning stock solution; wherein the mass ratio of the poly(lactic acid-co-glycolic acid) and the poly(ethylene glycol) block poly(γ-benzyl-L-methionine) amine is 20-24:76-80; (2) injecting the electrospinning stock solution into a syringe, and then performing electrospinning under the action of a propulsion pump, and the product is received by a cylindrical metal rotating receiving disk to obtain a blended spun yarn; (3) After the electrospinning process is completed and all the blended filaments are received by the cylindrical metal rotating receiving disk, the receiving speed of the receiving disk is adjusted to obtain a blended fiber membrane; (4) sending the blended fiber membrane obtained above into a vacuum drying oven for vacuum drying to remove the residual solvent, thereby obtaining the polyamino acid composite material having the function of promoting nerve repair; Wherein, in step (2), the injection speed during the electrospinning process is 1 to 3 ml / h, the loading voltage is 10 to 20 kV, and the receiving distance is 5 to 25 cm; The diameter of the blended spun yarn is 1.5 to 2.5 μm; The receiving speed of the cylindrical metal rotating receiving disk is adjusted to 700-2000 r / h.
2. The method for preparing the polyamino acid composite material having the function of promoting nerve repair according to claim 1, characterized in that: In step (1), the stirring is carried out at room temperature for 12 to 16 hours; and the organic solvent is selected from hexafluoroisopropanol or dichloromethane.
3. The method for preparing the polyamino acid composite material having the function of promoting nerve repair according to claim 1, characterized in that: In step (1), in the electrospinning stock solution, the mass percentage of the polylactic acid-glycolic acid copolymer is 8.6-12.3%.
4. The method for preparing the polyamino acid composite material having the function of promoting nerve repair according to claim 1, characterized in that: In step (1), the mass percentage of the poly(ethylene glycol)-block poly(γ-benzyl-L-methionine) is 18.2-23.1%.
5. The method for preparing the polyamino acid composite material having the function of promoting nerve repair according to claim 1, characterized in that: In step (4), the vacuum degree of the vacuum drying is 0.03Mpa to 0.06Mpa, the temperature is 18°C to 23°C, and the time is 36 to 48 hours.
6. An application of a polyamino acid composite material having a function of promoting nerve repair obtained by the preparation method according to any one of claims 1 to 5, characterized in that: Used for preparing biomedical nerve repair sleeves.
